MK-0000-176

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-176, covering 2012-05-28 to 2012-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Early Airway Response to Allergen in Asthmatics (MK-0000-176) [Phase 1]